IDT and Hamilton collaborate to develop automated scripts for customizable next-generation sequencing research components across liquid handling platforms.
Integrated DNA Technologies (IDT) and Hamilton have formed a strategic partnership to automate next-generation sequencing (NGS) workflows, aiming to accelerate genomic discoveries through customizable research solutions.
The global agreement will focus on developing automation scripts for IDT’s xGen and Archer NGS products for use on Hamilton’s Microlab STAR and NIMBUS liquid handling platforms. The collaboration is designed to provide laboratories with automated capabilities for identifying biomarkers in cancer research and other genomic applications.
“At IDT, we believe that innovation happens when scientists have the freedom to design workflows that fit their research needs,” says Ajay Gannerkote, president of IDT, in a release. “By pairing IDT’s flexible NGS solutions with Hamilton’s automation expertise, we’re removing constraints that may arise from one-size-fits-all approaches so labs can consistently and reliably accelerate their discoveries with confidence, precision, and speed, at whatever scale their work demands.”
Addressing Laboratory Efficiency Challenges
The partnership aims to address laboratory needs for scalable, modular solutions that can adapt to evolving research demands while maintaining precision and consistency. The automation is intended to reduce time spent on manual processes, allowing researchers to focus on data generation and analysis.
Hamilton’s liquid handling platforms will integrate with IDT’s portfolio of platform-agnostic solutions designed for solid tumor and blood cancer research applications. The collaboration supports IDT’s existing NGS sample-to-report assay offerings across various laboratory configurations.
“Hamilton is proud to partner with IDT to bring flexible, automation-ready NGS workflows to the global research community,” says Michael Mouradian, vice president of scientific strategy and market development at Hamilton, in a release. “By combining Hamilton’s precision engineering and trusted liquid handling platforms with IDT’s innovative assay solutions, we are enabling laboratories to achieve greater scalability, consistency, and efficiency in their genomic discoveries.”
Market Impact and Implementation
The partnership expands automated NGS capabilities globally, targeting laboratories conducting biomarker discovery research. The collaboration builds on both companies’ existing market positions—IDT as a genomics provider and Hamilton as a laboratory automation technology manufacturer.
Hamilton maintains manufacturing facilities in Reno, Nevada, and Bonaduz, Switzerland, with global ISO 9001 certification. The company serves life science, clinical diagnostics, forensics, and biotechnology industries through its liquid handling workstations and automation technology.
IDT, part of Danaher, has evolved from oligonucleotide manufacturing to genomics solutions provision. The company’s NGS portfolio includes research-use-only products not intended for clinical diagnostic applications.
ID 25953046 © Anyaivanova | Dreamstime.com
